Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Naltrexone on Cue-Induced Amphetamine Craving
2006-000837-36Phase 2Completed
- Sponsor
- Beroendecentrum Stockholm
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of naltrexone in amphetamine dependence, sponsored by Beroendecentrum Stockholm. Primary endpoint: Cue-induced subjectively reported amphetamine craving. Started Apr 2006; status: completed.
02
Drugs
naltrexone
03
Conditions
amphetamine dependence
Beyond the preview
Go deeper on 2006-000837-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000837-36.